• Company News
  • Food for Thought
  • Calendar & Events
  • Business Life
  • Company News: Micromet Reports Fourth Quarter and Full Year 2009 Financial Results


    Thursday, March 4, 2010

    Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009.  The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.

    Further details can be found at: www.micromet-inc.com

    Post to Twitter

    Leave a Reply


    In order to submit a comment, you need to mention your name and your email address (which won't be published). And ... don't forget your comment!

    Comment Form